These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9125147)

  • 1. Mutations of the INK4a locus in squamous cell carcinomas of human skin.
    Kubo Y; Urano Y; Matsumoto K; Ahsan K; Arase S
    Biochem Biophys Res Commun; 1997 Mar; 232(1):38-41. PubMed ID: 9125147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4a-ARF mutations in skin carcinomas from UV irradiated hairless mice.
    Soufir N; Queille S; Mollier K; Roux E; Sarasin A; de Gruijl FR; Fourtanier AM; Daya-Grosjean L; Basset-Seguin N
    Mol Carcinog; 2004 Apr; 39(4):195-8. PubMed ID: 15057871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM
    Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
    Esteller M; Tortola S; Toyota M; Capella G; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2000 Jan; 60(1):129-33. PubMed ID: 10646864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization.
    Munro J; Stott FJ; Vousden KH; Peters G; Parkinson EK
    Cancer Res; 1999 Jun; 59(11):2516-21. PubMed ID: 10363964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
    Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
    J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
    Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
    Soufir N; Basset-Seguin N
    Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 UV mutations in human skin epithelial tumors.
    Soufir N; Molès JP; Vilmer C; Moch C; Verola O; Rivet J; Tesniere A; Dubertret L; Basset-Seguin N
    Oncogene; 1999 Sep; 18(39):5477-81. PubMed ID: 10498902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
    Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
    Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.